US abortion pill access could hinge on whether doctors 

A prominent U.S. lawsuit to ban the abortion pill mifepristone has focused on the drug's safety and approval process. But the outcome may ultimately rest on a different issue: whether Ingrid Skop, an anti-abortion doctor in Texas, and other physicians behind the lawsuit can justify suing in the first place.

Related Keywords

United States , Louisiana , Delaware , Texas , Amarillo , Michigan , New Orleans , America , Ingrid Skop , Matthew Kacsmaryk , Tom Hals , Deepa Babington , Leah Litman , Erin Hawley , Amy Stevens , Thomson Reuters Trust Principles , Us Supreme Court , Supreme Court Justice Samuel Alito , Alliance For Hippocratic Medicine , Us Fifth Circuit Court , Circuit Court , University Of Michigan Law School , Supreme Court , Us District Court , Reuters , Drug Administration , Alliance Defending Freedom , Clapperv Amnesty International , Michigan Law School , Hippocratic Medicine , Judge Matthew Kacsmaryk , Amnesty International , Danco Laboratories , Thomson Reuters Trust , Nrlpa Ohlt , Rsbi Human Rights , Rsbi Regulatory Oversight , Rhpi Corporate Structure , Rhpi Regulatory , Rhpi Lawsuits , Rhpi Government Health Policy , Mtpix , Bact , Biz , Civ , Clj , Dli , Drugen , Gen , Genhlt , Hcpol , Hea , Heca , Hrgt , Judic , Law , Medreg , Mngiss , News1 , Phag08 , Phar , Phar08 , Phmr , Pol , Regs , Scotus , Soci , Wash , Wom , Womhea , Gamers , Us , Namer , Usatx , Legal , Reuters Legal , Oman , Ef Business Future Of Health , Nrlpa Olit ,